Companies · Medical Devices
San Francisco · CA, USA · Medical Devices · founded 2020 · http://www.avion.health
Diligence memoA one-page analyst read on Avion — recommendation, valuation, rhythm, risks.→Avion: limited disclosed financing to assess.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
Avion is one of 233 Medical Devices companies tracked from San Francisco, CA, USA, on record since 2020. By capital raised it ranks in the long tail (ahead of 13% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
Avion builds and operates autonomous eVTOL drones that deliver vital…
Avion is a drone-based digital health platform, designed to bridge the gap between remote clinics and urban healthcare infrastructures. By connecting these isolated clinics with sophisticated labs and well-stocked pharmacies in cities, Avion brings a new era of remote diagnostics and prescription fulfilment. Avion ensures the rapid, safe, and efficient delivery of vital medical supplies and clinical samples, even to the most hard-to-reach locations. Avion's operation uniquely combines cutting-edge autonomous drone technology with digital health platforms. Our drones, built with advanced eVTOL capabilities, ensure seamless take-off and landing capabilities, even in challenging terrains. Avion's digital health platform serves as the connective tissue between urban health centers and remote clinics. The platform features an intuitive interface, making it easy for healthcare providers to order necessary supplies, track shipments, and even communicate with laboratory and pharmacy staff.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
No round amounts on record to chart.
No staged rounds to sequence.
Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 13% of sector peers (real $). Modeled value above 13% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| No rounds recorded. | |||||
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Avion is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| 7D Surgical Inc. | Medical Devices | Pre-Seed | $581K | $21.4M | same sector |
| Accessible Diagnostics LLC | Medical Devices | Pre-Seed | $719K | $8.1M | same sector |
| Acera Surgical, Inc. | Medical Devices | Series A | $6.2M | $123.6M | same sector |
| ACES Diagnostics, Inc. | Medical Devices | Seed | $1.6M | $7.3M | same sector |
| Active Genomes Expressed Diagnostics Corp | Medical Devices | Pre-Seed | $250K | $2.4M | same sector |
| ACTIV Surgical, Inc. | Medical Devices | Series C | $86.6M | $239.9M | same sector |
| Acuamark Diagnostics, Inc. | Medical Devices | Series A | $20.3M | $25.6M | same sector |
| ADM Diagnostics, Inc. | Medical Devices | Pre-Seed | $620K | $22.8M | same sector |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| AVION UAV Inc. | Other | Series A | $28.5M | 75% |
| Avro Life Science Skin patches for generic drug delivery. | Biotech | — | — | 74% |
| Autonomous Medical Devices Inc | Healthtech | Series D+ | $2.8B | 72% |
| Avion School We teach Filipinos to become remote software engineers globally. | Edtech | — | — | 72% |
| Akute Health The medical record & infrastructure stack for digital health companies | Healthtech | — | — | 72% |
| Iris Automation Enabling autonomous drone operations globally through AI software | Robotics | — | — | 72% |
| Legion Health, Inc. Autonomous medical care | Healthtech | Seed | $1.0M | 71% |
| Droneify Holdings Ltd | Robotics | Pre-Seed | $2.6M | 71% |
See where Avion sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Avion, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.